Clinical Trial Update: Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise Therapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating adding metformin to SYR-322 in type 2 diabetes patients inadequately controlled on SYR-322 plus lifestyle changes; completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Metformin Hydrochloride 500 mg (metformin)
• SYR-322 25 mg

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2016-06-06